Minimal important differences and response shift in health-related quality of life; a longitudinal study in patients with multiple myeloma

Health and Quality of Life Outcomes

Volumn 8, Issue , 2010, Pages

  Kvam, Ann K ^a,b   Wisløff, Finn ^a,b   Fayers, Peter M ^c,d  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c UNIVERSITY OF ABERDEEN   (United Kingdom)

^d NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL TRIAL; FATIGUE; FEMALE; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; PAIN; PHYSICAL ACTIVITY; QUALITY OF LIFE; STATISTICAL SIGNIFICANCE; ANALYSIS OF VARIANCE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HEALTH SURVEY; INTERVIEW; MIDDLE AGED; NORWAY; PSYCHOLOGICAL ASPECT; PSYCHOMETRY; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; REPRODUCIBILITY; RETROSPECTIVE STUDY; STANDARD;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; FEMALE; HEALTH STATUS INDICATORS; HUMANS; INTERVIEWS AS TOPIC; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MULTIPLE MYELOMA; NORWAY; PSYCHOMETRICS; QUALITY OF LIFE; QUESTIONNAIRES; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES;

EID: 77955099042     PISSN: None     EISSN: 14777525     Source Type: Journal    
DOI: 10.1186/1477-7525-8-79     Document Type: Article

References (33)

1. Howard GS, Ralph KM, Gulanick NA, Maxwell SE, Nance DW, Gerber SK. Internal Invalidity in Pretest-Posttest Self-Report Evaluations and a Re-evaluation of Retrospective Pretests. Applied Psychological Measurement 1979, 3:1-23.
2. Sprangers MA, Schwartz CE. Integrating response shift into health-related quality of life research: a theoretical model. Soc Sci Med 1999, 48:1507-15. 10.1016/S0277-9536(99)00045-3, 10400253.
3. Schwartz CE, Sprangers MA. Methodological approaches for assessing response shift in longitudinal health-related quality-of-life research. Soc Sci Med 1999, 48:1531-48. 10.1016/S0277-9536(99)00047-7, 10400255.
4. Visser MR, Smets EM, Sprangers MA, de Haes HJ. How response shift may affect the measurement of change in fatigue. J Pain Symptom Manage 2000, 20:12-8. 10.1016/S0885-3924(00)00148-2, 10946164.
5. Jansen SJ, Stiggelbout AM, Nooij MA, Noordijk EM, Kievit J. Response shift in quality of life measurement in early-stage breast cancer patients undergoing radiotherapy. Qual Life Res 2000, 9:603-15. 10.1023/A:1008928617014, 11236851.
6. Sharpe L, Butow P, Smith C, McConnell D, Clarke S. Changes in quality of life in patients with advanced cancer: evidence of response shift and response restriction. J Psychosom Res 2005, 58:497-504. 10.1016/j.jpsychores.2005.02.017, 16125516.
7. Hagedoorn M, Sneeuw KC, Aaronson NK. Changes in physical functioning and quality of life in patients with cancer: response shift and relative evaluation of one's condition. J Clin Epidemiol 2002, 55:176-83. 10.1016/S0895-4356(01)00438-3, 11809356.
8. Bernhard J, Hurny C, Maibach R, Herrmann R, Laffer U. Quality of life as subjective experience: reframing of perception in patients with colon cancer undergoing radical resection with or without adjuvant chemotherapy. Swiss Group for Clinical Cancer Research (SAKK). Ann Oncol 1999, 10:775-82. 10.1023/A:1008311918967, 10470423.
9. Rees J, Waldron D, O'Boyle C, Ewings P, MacDonagh R. Prospective vs retrospective assessment of lower urinary tract symptoms in patients with advanced prostate cancer: the effect of 'response shift'. BJU Int 2003, 92:703-6. 10.1046/j.1464-410X.2003.04462.x, 14616450.
10. Andrykowski MA, Donovan KA, Jacobsen PB. Magnitude and correlates of response shift in fatigue ratings in women undergoing adjuvant therapy for breast cancer. J Pain Symptom Manage 2009, 37:341-51. 10.1016/j.jpainsymman.2008.03.015, 2682229, 18757176.
11. Schwartz CE, Bode R, Repucci N, Becker J, Sprangers MA, Fayers PM. The clinical significance of adaptation to changing health: a meta-analysis of response shift. Qual Life Res 2006, 15:1533-50. 10.1007/s11136-006-0025-9, 17031503.
12. Kvam AK, Fayers P, Wisloff F. What changes in health-related quality of life matter to multiple myeloma patients? A prospective study. Eur J Haemato 2010, 84:345-53.
13. Sirohi B, Powles R. Epidemiology and outcomes research for MGUS, myeloma and amyloidosis. Eur J Cancer 2006, 42:1671-83. 10.1016/j.ejca.2006.01.065, 16870424.
14. Gulbrandsen N, Hjermstad MJ, Wisloff F. Interpretation of quality of life scores in multiple myeloma by comparison with a reference population and assessment of the clinical importance of score differences. Eur J Haematol 2004, 72:172-80. 10.1046/j.0902-4441.2003.00195.x, 14962235.
15. Jaeschke R, Singer J, Guyatt GH. Measurement of health status. Ascertaining the minimal clinically important difference. Control Clin Trials 1989, 10:407-15. 10.1016/0197-2456(89)90005-6, 2691207.
16. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JC. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993, 85:365-76. 10.1093/jnci/85.5.365, 8433390.
17. Fayers PM, Aaronson NK, Bjordal K, Groenvold M, Curran D, . Bottomley A on behalf of the EORTC Quality of life group The EORTC QLQ-C30 Scoring Manual. 2001, European Organisation for Research and Treatment of Cancer, Brussels, 3, Bottomley A on behalf of the EORTC Quality of life group.
18. Wisloff F, Eika S, Hippe E, Hjorth M, Holmberg E, Kaasa S, Palva I, Westin J. Measurement of health-related quality of life in multiple myeloma. Nordic Myeloma Study Group. Br J Haematol 1996, 92:604-13. 10.1046/j.1365-2141.1996.352889.x, 8616024.
19. Cohen J. Statistical power analysis for the behavioral sciences 1988, Hillsdale, N. J.: Laurence Erlbaum.
20. Fayers PM, Machin D. Quality of life: the assessment, analysis, and interpretation of patient-reported outcomes 2007, Chichester: J. Wiley.
21. Sprangers MA, Van Dam FS, Broersen J, Lodder L, Wever L, Visser MR, Oosterveld P, Smets EM. Revealing response shift in longitudinal research on fatigue--the use of the thentest approach. Acta Oncol 1999, 38:709-18. 10.1080/028418699432824, 10522761.
22. Gulbrandsen N, Wisloff F, Brinch L, Carlson K, Dahl IM, Gimsing P, Hippe E, Hjorth M, Knudsen LM, Lamvik J, Lenhoff S, Lofvenberg E, Nesthus I, Nielsen JL, Turesson I, Westin J. Health-related quality of life in multiple myeloma patients receiving high-dose chemotherapy with autologous blood stem-cell support. Med Oncol 2001, 18:65-77. 10.1385/MO:18:1:65, 11778972.
23. Dubois D, Dhawan R, van d V, Esseltine D, Gupta S, Viala M, de la Loge C. Descriptive and prognostic value of patient-reported outcomes: the bortezomib experience in relapsed and refractory multiple myeloma. J Clin Oncol 2006, 24:976-82. 10.1200/JCO.2005.04.0824, 16432077.
24. Ring L, Hofer S, Heuston F, Harris D, O'Boyle CA. Response shift masks the treatment impact on patient reported outcomes (PROs): the example of individual quality of life in edentulous patients. Health Qual Life Outcomes 2005, 3:55-62. 10.1186/1477-7525-3-55, 1236951, 16146573.
25. Razmjou H, Schwartz CE, Yee A, Finkelstein JA. Traditional assessment of health outcome following total knee arthroplasty was confounded by response shift phenomenon. J Clin Epidemiol 2009, 62:91-6. 10.1016/j.jclinepi.2008.08.004, 19095168.
26. Vogelzang NJ, Breitbart W, Cella D, Curt GA, Groopman JE, Horning SJ, Itri LM, Johnson DH, Scherr SL, Portenoy RK. Patient, caregiver, and oncologist perceptions of cancer-related fatigue: results of a tripart assessment survey. The Fatigue Coalition. Seminars in Hematology 1997, 34(3 Suppl 2):4-12.
27. Norman G. Hi! How are you? Response shift, implicit theories and differing epistemologies. Qual Life Res 2003, 12:239-49. 10.1023/A:1023211129926, 12769136.
28. Fayers PM, Hays RD. Assessing quality of life in clinical trials: methods and practice. 2005, Oxford: Oxford University Press.
29. Visser MR, Oort FJ, Sprangers MA. Methods to detect response shift in quality of life data: a convergent validity study. Qual Life Res 2005, 14:629-39. 10.1007/s11136-004-2577-x, 16022057.
30. Johnsen AT, Tholstrup D, Petersen MA, Pedersen L, Groenvold M. Health related quality of life in a nationally representative sample of haematological patients. Eur J Haematol 2009, 83:139-48. 10.1111/j.1600-0609.2009.01250.x, 2730555, 19284418.
31. Bottomley A, Therasse P, Piccart M, Efficace F, Coens C, Gotay C, Welnicka-Jaskiewicz M, Mauriac L, Dyczka J, Cufer T, Lichinitser MR, Schornagel JH, Bonnefoi H, Shepherd L. Health-related quality of life in survivors of locally advanced breast cancer: an international randomised controlled phase III trial. Lancet Oncol 2005, 6:287-94. 10.1016/S1470-2045(05)70100-5, 15863376.
32. Zenger M, Hinz A, Stolzenburg JU, Rabenalt R, Schwalenberg T, Schwarz R. Health-related quality of life of prostate cancer patients compared to the general German population: age-specific results. Urol Int 2009, 83:166-70. 10.1159/000230018, 19752611.
33. Turesson I, Velez R, Kristinsson SY, Landgren O. Patterns of Improved Survival in Patients With Multiple Myeloma in the Twenty-First Century: A Population-Based Study. J Clin Oncol 2010, 28:830-4. 10.1200/JCO.2009.25.4177, 20038719.